Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammationNCT04447469KNSAPhase 2, Phase 3Completed2021-11-12Actual
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-GuerinNCT04452591CGONPhase 3Active not recruiting2030-06-16Estimated
Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic PainNCT04455633Lexicon PharmaceuticalsPhase 2Completed2022-05-23Actual
A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAHNCT04457336Spruce BiosciencesPhase 2Terminated2024-02-09Actual
A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract CancersNCT04466891Jazz PharmaceuticalsPhase 2Completed2023-07-28Actual
Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 PneumoniaNCT04467840RedHill Biopharma LimitedPhase 2, Phase 3Completed2021-07-18Actual
Safety and Efficacy of TP-03 for the Treatment of Demodex BlepharitisNCT04475432TARSPhase 2, Phase 3Completed2021-05-04Actual
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)NCT04476017SUPNPhase 2Completed2022-03-25Actual
Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)NCT04480840PLRXPhase 2Completed2024-02-26Actual
Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled SeizuresNCT04485104Jazz PharmaceuticalsPhase 3Terminated2025-01-28Actual
ATH-1017 for Treatment of Mild to Moderate Alzheimer's DiseaseNCT04488419LeonaBioPhase 2, Phase 3Completed2024-07-15Actual
A Study of ATH-1017 in Mild to Moderate Alzheimer's DiseaseNCT04491006LeonaBioPhase 2Completed2022-05-20Actual
Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBMNCT04492163NovoCure GmbHPhase 2Completed2023-06-20Actual
CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLCNCT04495153CADLPhase 2Active not recruiting2024-12-31Actual
A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHLNCT04496349Ascentage Pharma Group Inc.Phase 2Recruiting2026-05-31Estimated
Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid TumorsNCT04504942CytoDyn, Inc.Phase 2Completed2021-11-07Actual
A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With FibromyalgiaNCT04508621Tonix Pharmaceuticals, Inc.Phase 3Completed2021-11-01Actual
Efficacy of MT-401 in Patients With AML Following Stem Cell TransplantNCT04511130MRKRPhase 2Terminated2024-03-01Actual
Losmapimod Safety and Efficacy in COVID-19NCT04511819Fulcrum TherapeuticsPhase 3Terminated2021-03-31Actual
An Open Label Study of ANX005 in Participants With, or at Risk for, Manifest Huntington's DiseaseNCT04514367ANNXPhase 2Completed2022-08-29Actual
A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal DisordersNCT04516278OTLKPhase 3Completed2021-02-10Actual
VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia CongenitaNCT04520750PVLAPhase 3Completed2021-06-30Actual
A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With AcromegalyNCT04522180IONSPhase 2Completed2022-07-15Actual
Evaluation of Maralixibat in Biliary Atresia Response Post-KasaiNCT04524390MIRMPhase 2Completed2023-11-07Actual
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)NCT04524403Corcept TherapeuticsPhase 2Completed2022-07-29Actual
Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)NCT04524858ACRSPhase 2Terminated2021-02-25Actual
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)NCT04525157Clinuvel Pharmaceuticals LimitedPhase 2Completed2016-02-02Actual
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of SchizophreniaNCT04531982ACADPhase 3Completed2024-01-25Actual
Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPFNCT04533022Vicore Pharma ABPhase 2Completed2024-03-30Actual
Tafenoquine in Patients With Mild to Moderate COVID-19NCT0453334760 Degrees Pharmaceuticals LLCPhase 2Completed2022-06-30Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.